Breaking

Post Top Ad

Your Ad Spot

Friday, 2 October 2020

Global markets retreat after Trump tests positive for Covid-19 – business live

Rolling coverage of the latest economic and financial news, as the US president confirms he has Covid-19

Amazon has revealed that almost 20,000 of its workers in the US have contracted Covid-19 after months of demands for public disclosure from activists, my colleague Jasper Jolly writes.

The US tech company has been one of the biggest corporate winners during the pandemic, with people across the world switching to online shopping during lockdowns. However, Amazon has faced criticism from some labour campaigners who alleged that the company put employees in danger by keeping warehouses open.

COVID-19 Testing Update: We’ve already launched and are ramping quickly, conducting thousands of tests a day and growing to 50,000 tests a day across 650 sites by November as part of our effort to keep our front-line employees safe. https://t.co/QMuJbRcfmM

Related: Almost 20,000 Amazon workers in US test positive for Covid-19

There’s a short update from AstraZeneca, which has been working on an experimental Covid-19 vaccine with the University of Oxford.

The British drugmaker said that clinical trials for the vaccine have resumed in Japan, but that it is still in talks with regulators over data needed to restart trials in the US, which is one of the countries where the trials had been put on pause.

AstraZeneca continues to work with the Food and Drug Administration (FDA) to facilitate review of the information needed to make a decision regarding resumption of the US trial. The safety of trial participants is of paramount importance and we are committed to upholding the highest standards of conduct in clinical trials.

Continue reading...

from The Guardian https://ift.tt/3liZIT9

Post Top Ad

Your Ad Spot